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Patients requiring emergency airway management are at great risk of hypoxemic hypoxia because of primary lung
pathology, high metabolic demands, anemia, insufficient respiratory drive, and inability to protect their airway
against aspiration. Tracheal intubation is often required before the complete information needed to assess the
risk of periprocedural hypoxia is acquired, such as an arterial blood gas level, hemoglobin value, or even a chest
radiograph. This article reviews preoxygenation and peri-intubation oxygenation techniques to minimize the risk of
critical hypoxia and introduces a risk-stratification approach to emergency tracheal intubation. Techniques
reviewed include positioning, preoxygenation and denitrogenation, positive end expiratory pressure devices, and
passive apneic oxygenation. [Ann Emerg Med. 2012;59:165-175.]
A podcast for this article is available at www.annemergmed.com.
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Maintaining hemoglobin saturation during airway management
is critical to patient safety. Desaturation to below 70% puts patients
at risk for dysrhythmia, hemodynamic decompensation, hypoxic
brain injury, and death.1,2 The challenge for emergency physicians
is to secure a tracheal tube rapidly without critical hypoxia or
aspiration. In patients without pulmonary pathology, adequate
hemoglobin, or low metabolic demands and an initial pulse
oximetry reading of 100% on room air, there is a low risk of
desaturation after adequate preoxygenation. Conversely, in a septic
patient with multilobar pneumonia who is already hypoxemic
(oxygen saturation 90%) despite 100% oxygen at high flow,
there is an immediate risk of critical tissue hypoxia during tracheal
intubation.
This article reviews preoxygenation and peri-intubation
oxygenation techniques to minimize the risk of hypoxemia
during emergency tracheal intubation of adult patients. It
introduces a risk-stratification approach based on initial pulse
oximetry level in response to oxygen administration and
provides recommendations about specific techniques based on
periprocedural risk. Techniques reviewed include positioning,
preoxygenation and denitrogenation, use of positive pressure
devices to increase mean airway pressure, and passive apneic
oxygenation during tracheal intubation efforts.
WHAT IS THE RATIONALE FOR PROVIDING
PREOXYGENATION BEFORE TRACHEAL
INTUBATION?
Preoxygenation allows a safety buffer during periods of
hypoventilation and apnea. It extends the duration of safe a
Volume , .  : March pnea, defined as the time until a patient reaches a saturation
evel of 88% to 90%, to allow for placement of a definitive
irway. When patients desaturate below this level, their status is
n the steep portion of the oxyhemoglobin dissociation curve
nd can decrease to critical levels of oxygen saturation (70%)
ithin moments (Figure 1).3
The standard anesthesia induction of elective operative patients
s performed by administering a sedative, providing manual
entilations, administering a muscle relaxant, and then continuing
anual ventilations until placement of a definitive airway.
reoxygenation is not mandatory in these patients because
entilation is continued throughout the induction period and
ecause they have normal physiology and low metabolic needs.
For operative patients with high aspiration risk caused by
owel pathology, body habitus, or critical illness,
nesthesiologists developed rapid sequence induction. As
riginally conceived, this technique is the simultaneous
dministration of the sedative and paralytic with no ventilation
hile waiting for the paralytic to take effect, unless needed to
revent hypoxemia. This induction method has been adapted to
he emergency department (ED), where all patients requiring
irway management are assumed to be at risk for aspiration; our
efault technique is a rapid sequence tracheal intubation.
In a patient breathing room air before rapid sequence
racheal intubation (PaO2 90 to 100 mm Hg), desaturation
ill occur in the 45 to 60 seconds between sedative/paralytic
dministration and airway placement. In the 1950s,
nesthesiologists realized that the safest way to perform rapid
equence tracheal intubation would be by filling the patient’s
lveoli with a high fraction of inspired oxygen (FiO2) before the










































Preoxygenation and Prevention of Desaturation During Emergency Airway Management Weingart & Levitanprocedure.4 Studies by Heller and Watson5 and Heller et al6
show markedly increased time to desaturation if the patients
received preoxygenation with 100% oxygen rather than room
air before tracheal intubation.5,6
For preoxygenation in the ED, we have 3 goals: (1) to bring
the patient’s saturation as close to 100% as possible; (2) to
denitrogenate the residual capacity of the lungs (maximizing
oxygen storage in the lungs); and (3) to denitrogenate and
maximally oxygenate the bloodstream.7 The first 2 goals are
imperative; denitrogenating and oxygenating the blood adds
little to the duration of safe apnea8 because oxygen is poorly
soluble in blood, and the bloodstream is a comparatively small
oxygen reservoir compared with the lungs (5% versus 95%).
Recommendation: Preoxygenation extends the duration of
safe apnea and is recommended for every ED tracheal
intubation.
WHAT IS THE BEST SOURCE OF HIGH FIO2 FOR
PREOXYGENATION?
The duration of safe apnea times in most of the
preoxygenation literature is predicated on anesthesia circuits
that are capable of delivering 90% to 100% FiO2 when used
with a well-fitting mask. However, the usual source of oxygen
during ED preoxygenation is a facemask with an oxygen
reservoir. This device is erroneously referred to as the
nonrebreather mask despite an absence of 1-way valves covering
all of its ports. True nonrebreather masks set at 15 L/minute for
patients with normal ventilatory patterns are capable of
delivering near 90% FiO2,
9 but these devices are rarely available
in EDs. Standardly available nonrebreather masks at flow rates
of 15 L/minute deliver only 60% to 70% FiO2, do not provide
complete denitrogenation, and accordingly do not maximize the
Figure 1. Oxyhemoglobin dissociation curve demonstrates
the SpO2 from various levels of PaO2. Risk categories are
overlaid on the curve. Patients near an SpO2 of 90% are at
risk for precipitous desaturation, as demonstrated by the
shape of the curve.duration of safe apnea.9 p
166 Annals of Emergency MedicineStandardly available nonrebreather masks can deliver FiO2
reater than or equal to 90% by increasing the flow rate to 30 to
0 L/minute.10 Such flow rates may be achievable on most flow
egulators in EDs by continuing to open the valve, though there
ill be no calibrated markings beyond 15 L/minute.
Some ED providers use the self-inflating bag-valve-mask
evice to provide preoxygenation. Bag-valve-mask devices
acking 1-way inhalation and exhalation ports will deliver only
lose to room air FiO2 when not actively assisting
entilations.11,12 Even with ideal 1-way valves, the devices will
eliver oxygen only in 2 circumstances: the patient generates
nough inspiratory force to open the valve or the practitioner
queezes the bag. In both circumstances, to obtain any FiO2
bove that of room air, a tight seal must be achieved with the
ask, which usually requires a 2-handed technique.13 A bag-
alve-mask device hovering above the patient’s face provides
nly ambient FiO2.
Recommendation: Standard reservoir facemasks with the
ow rate of oxygen set as high as possible are the recommended
ource of high FiO2 for preoxygenation in the ED.
OR WHAT PERIOD OF TIME SHOULD THE
ATIENT RECEIVE PREOXYGENATION?
Ideally, patients should continue to receive preoxygenation
ntil they denitrogenate the functional residual capacity of their
ungs sufficiently to achieve greater than 90% end-tidal oxygen
evel.14 Although the mass spectrometers in many EDs allow the
easurement of end-tidal oxygen levels, in practice this is rarely
erformed. Instead, expediency often demands an empiric
iming of preoxygenation.
Three minutes’ worth of tidal-volume breathing (the
atient’s normal respiratory pattern) with a high FiO2 source is
n acceptable duration of preoxygenation for most patients.15,16
his tidal-volume breathing approach can be augmented by
sking the patient to exhale fully before the 3-minute
eriod.17,18
Cooperative patients can be asked to take 8 vital-capacity
reaths (maximal exhalation followed by maximal
nhalation).16,19,20 This method generally can reduce the
reoxygenation time to approximately 60 seconds.16
nfortunately, many ill ED patients cannot take vital-capacity
reaths.
The above times are predicated on a source of FiO2 greater
han or equal to 90% and a tightly fitting mask that prevents
ntrainment of room air.21
Recommendation: Patients with an adequate respiratory
rive should receive preoxygenation for 3 minutes or take 8
reaths, with maximal inhalation and exhalation.
AN INCREASING MEAN AIRWAY PRESSURE
UGMENT PREOXYGENATION?
Mean airway pressure may be increased during
reoxygenation through the use of techniques such as


















Weingart & Levitan Preoxygenation and Prevention of Desaturation During Emergency Airway Managementnoninvasive positive-pressure ventilation. If patients have not
achieved a saturation greater than 93% to 95% before tracheal
intubation, they have a higher likelihood of desaturation during
their apneic and tracheal intubation periods.2,16,18,22,23 If
patients do not achieve this saturation level after 3 minutes of
tidal-volume breathing with a high FiO2 source, it is likely that
they are exhibiting shunt physiology; any further augmentation
of FiO2 will be unhelpful.
24 Shunt physiology refers to alveoli
that are perfused but not ventilated because of conditions such
as pulmonary edema or pneumonia, in which the alveoli are
filled with fluid or collapsed. The net effect is a physiologic
right-to-left shunt; blood coming from the pulmonary arteries is
returned to the pulmonary veins without oxygenation. In the
short term, shunt physiology can be partially overcome by
augmenting mean airway pressure, thereby improving the
effectiveness of preoxygenation and extending the safe apnea
time.
Evidence for the use of increased mean airway pressure as a
Table 1. Evidence for increased mean airway pressure as a pre
Study Patients Intervention
Delay et al25 RCT of 28 obese,
operative patients
Noninvasive ventilation
Futier et al26 RCT of 66 obese,
operative patients













Herriger et al29 RCT of 40 ASA I–II
operative patients
CPAP preoxygenation





RCT, Randomized controlled trial; NPPV, noninvasive positive-pressure ventilation
can Society of Anesthesiologists; TI, tracheal intubation.preoxygenation technique can be found in Table 1. In a study H
Volume , .  : March articularly relevant to the ED, Baillard et al23 examined
ypoxemic critically ill patients requiring tracheal intubation in
he ICU. At the end of the preoxygenation period, the
oninvasive positive-pressure ventilation group had a 98%
ean SpO2, whereas the standard group had one of 93%. In the
oninvasive positive-pressure ventilation group, 6 of 26 patients
ere unable to improve their hypoxemic saturations with high
iO2 until they received positive pressure. During the tracheal
ntubation procedure, the standard group’s levels decreased to
aturations of 81% compared with 93% in the noninvasive
ositive-pressure ventilation group. Twelve of the control group
nd 2 of the noninvasive positive-pressure ventilation group had
aturation levels below 80%.
No negative cardiovascular effects27,31 or appreciable gastric
istention was observed in noninvasive positive pressure
reoxygenation studies.25 The latter result was likely due to the
ow pressures used in these studies; gastric distention and





The patients in the noninvasive
positive-pressure ventilation











At the end of preoxygenation,
PaO2 was higher in the NPPV
and NPPVRM groups
compared with the spont
vent group and remained




Showed a 40-s increase in
time to desaturation through






The time until reaching a
saturation of 90% after
apnea was extended by a
minute in the CPAP group
Spontaneous ventilation
at zero pressure
Application of positive airway
pressure during induction of
anesthesia in adults
prolongs the nonhypoxic
apnea duration by 2 min
Spontaneous ventilation
at zero pressure
The PaO2/FiO2 ratio improved
in the noninvasive positive-
pressure ventilation group
and worsened in the high-
FiO2-alone group






32-35 The data on the absence of any cardiovascular side













































Preoxygenation and Prevention of Desaturation During Emergency Airway Management Weingart & Levitaneffects may not be applicable to volume-depleted critically ill
patients.36
The benefits of noninvasive positive-pressure ventilation for
preoxygenation in the ED should primarily be observed in
patients who cannot achieve acceptable saturations with high
FiO2 alone.
31 If tracheal intubation is attempted with
saturations below 90%, these patients can critically desaturate in
seconds.37 Positive pressure may be applied with standalone
disposable continuous positive airway pressure (CPAP) masks38;
with CPAP masks connected to noninvasive machines or
standard ventilators; or by using a positive end-expiratory
pressure (PEEP) valve on a standard bag mask (Figure 2). Even
in departments without immediate CPAP systems, single-use
PEEP valves are inexpensive and require minimal modification
of practice.
In critically ill patients with very high degrees of shunting,
apneic oxygenation (discussed below) alone is unlikely to be
helpful.39 If patients require CPAP during their preoxygenation
period, it may benefit them to have the device left on until the
moment of tracheal intubation. Whatever predisposed them to
experience shunting will recur during the apneic period if they
remain at zero airway pressure.40 PEEP also prevents absorption
atelectasis caused by breathing high FiO2 gas level, increasing
the efficacy of apneic oxygenation.41
Recommendation: CPAP masks, noninvasive positive-
Figure 2. A disposable PEEP valve. This inexpensive item
is a strain gauge capable of PEEP settings from 5 to 20
cm H2O. When placed on the exhalation port of a bag-
valve-mask device (inset), it allows the device to provide
PEEP/CPAP when the patient is spontaneously breathing
and during assisted ventilations. If combined with a nasal
cannula set to 15 L/minute, it will provide CPAP even
without ventilations. The generation of positive pressure is
predicated on a tight mask seal.pressure ventilation, or PEEP valves on a bag-valve-mask device o
168 Annals of Emergency Medicinehould be considered for preoxygenation and ventilation during
he onset phase of muscle relaxation in patients who cannot
chieve saturations greater than 93% to 95% with high FiO2.
N WHAT POSITION SHOULD THE PATIENT
ECEIVE PREOXYGENATION?
Supine positioning is not ideal to achieve optimal
reoxygenation. When one is placed flat, it is more difficult to
ake full breaths and more of the posterior lung becomes prone
o atelectatic collapse,3 which reduces the reservoir of oxygen
ontained within the lungs and therefore reduces safe apnea
ime.
Lane et al42 performed a randomized controlled trial of
atients preoxygenated in a 20-degree head-up position
ersus a control group that was left supine. After 3 minutes
f preoxygenation, the patients received sedation and muscle
elaxation and were then allowed to decrease their saturation
rom 100% to 95%. The head-up group took 386 seconds to
each this saturation versus 283 seconds in the control
roup.42 Recently, Ramkumar et al43 confirmed these results,
ith the 20-degree head-up group taking 452 seconds to
esaturate versus 364 seconds for the supine group.
Altermatt et al44 examined specifically preoxygenation in
bese patients (body mass index 35). This randomized
ontrolled trial compared safe apnea times in intubated
atients who received preoxygenation in a sitting position
ompared with those preoxygenated while lying flat. After
apid sequence induction of anesthesia, the trachea was
ntubated and the patient was left apneic and disconnected
rom the anesthesia circuit until SpO2 level decreased from
00% to 90%. Using the time taken for desaturation to 90%
s the outcome, the patients preoxygenated in a sitting
osition took 214 seconds to desaturate versus 162 seconds
or patients preoxygenated while lying flat.44 Dixon et al45
howed similar benefits in a third randomized controlled trial
n patients with body mass index greater than 40 who were
laced in the 25-degree head-up position.
Reverse Trendelenburg position (head of stretcher 30 degrees
igher than the foot) also improves preoxygenation and may be
seful in patients who cannot bend at the waist or shoulders, ie,
hose immobilized for possible spinal injury.46
An additional benefit of head elevation is better laryngeal
xposure during direct laryngoscopy.47
Recommendation: Patients should receive preoxygenation in
head-elevated position whenever possible. For patients
mmobilized for possible spinal injury, reverse Trendelenburg
osition can be used.
OW LONG WILL IT TAKE FOR THE PATIENT
O DESATURATE AFTER PREOXYGENATION?
Although breathing at a high FiO2 level will slightly
ncrease the bloodstream stores of oxygen, the primary
enefit of preoxygenation is the creation of a reservoir of
xygen in the alveoli. When a patient is breathing room air,


















































Weingart & Levitan Preoxygenation and Prevention of Desaturation During Emergency Airway Management450 mL of oxygen is present in the lungs; this amount
increases to 3,000 mL when a patient breathes 100% oxygen
for a sufficient time to replace the alveolar nitrogen. A
patient breathing room air will have a total oxygen reservoir
in the lungs and bloodstream of approximately 1.0 to 1.5 L,
whereas an optimally preoxygenated patient will have 3.5 to
4.0 L.3 Oxygen consumption during apnea is approximately
250 mL/minute (3 mL/kg per minute); in healthy patients,
the duration of safe apnea on room air is approximately 1
minute compared with approximately 8 minutes when
breathing at a high FiO2 level.
3
Benumof et al48 used physiologic modeling to calculate
the time to desaturation less than 90% after the
administration of succinylcholine for various patient groups
after apnea. The times were 8 minutes, 5 minutes, and 2.7
minutes for healthy adults, moderately ill adults, and obese
adults, respectively.
The desaturation curves of Benumof et al48 have been
extensively reproduced in the emergency medicine literature,
but the extended times in these models are predicated on
factors that are very different from those present in many
emergency tracheal intubations. The curves assume complete
denitrogenation and alveolar concentrations of oxygen at
80%. The model by Benumof et al48 assumes preoxygenation
with a device capable of generating approximately 90% FiO2
and optimal time for preoxygenation. It also ignores pulse
oximeter lag time. In sick patients, especially those with poor
cardiac output, the readings on a finger-probe pulse oximeter
may lag behind the actual central arterial circulation by 30 to
60 seconds.49 The times depicted by the desaturation curves
are not applicable to critically ill ED patients or those with
poor cardiac output.50-52
The effect of shunting, increased metabolic demand, anemia,
volume depletion, and decreased cardiac output are synergistic
in dramatically reducing oxygen storage in the lungs and
shortening safe apnea in critically ill patients. As calculated by
Farmery and Roe,51 desaturation to 85% may be as short as 23
seconds in critically ill patients versus 502 seconds in a healthy
adult.51
Mort52 studied ICU patients with blood gas measurements
before and after preoxygenation, using bag-valve-mask
ventilation. Average PaO2 was only 67 mm Hg at baseline and
increased to a mean of only 104 mm Hg after 4 minutes of bag-
valve-mask ventilation. In less than 20% of patients did
preoxygenation increase the PaO2 by 50 mm Hg. The author’s
conclusion was that preoxygenation is only marginally effective
in critically ill patients. It is important for clinicians to
appreciate that PaO2 values in this range are on the steep section
of the pulse oximetry curve (Figure 1).
Recommendation: Given the unique variables involved in
each ED tracheal intubation, it is impossible to predict the
exact duration of safe apnea in a patient. Patients with high
saturation levels on room air or after oxygen administration
are at lower risk and may maintain adequate oxygen h
Volume , .  : March aturation as long as 8 minutes. Critically ill patients and
hose with values just above the steep edge of the
esaturation curve are at high risk of hypoxemia with
rolonged tracheal intubation efforts and may desaturate
mmediately.
AN APNEIC OXYGENATION EXTEND THE
URATION OF SAFE APNEA?
Alveoli will continue to take up oxygen even without
iaphragmatic movements or lung expansion. In an apneic
atient, approximately 250 mL/minute of oxygen will move
rom the alveoli into the bloodstream. Conversely, only 8 to 20
L/minute of carbon dioxide moves into the alveoli during
pnea, with the remainder being buffered in the bloodstream.53
he difference in oxygen and carbon dioxide movement across
he alveolar membrane is due to the significant differences in gas
olubility in the blood, as well as the affinity of hemoglobin for
xygen. This causes the net pressure in the alveoli to become
lightly subatmospheric, generating a mass flow of gas from
harynx to alveoli. This phenomenon, called apneic
xygenation, permits maintenance of oxygenation without
pontaneous or administered ventilations. Under optimal
ircumstances, a PaO2 can be maintained at greater than 100
m Hg for up to 100 minutes without a single breath, although
he lack of ventilation will eventually cause marked hypercapnia
nd significant acidosis.54
Apneic oxygenation is not a new concept; it has been
escribed in the medical literature for more than a century, with
ames such as apneic diffusion oxygenation, diffusion
espiration, and mass flow ventilation.55,56 A summary of
uman evidence for apneic oxygenation is available as a
upplement to this article (Table E1, available online at http://
ww.annemergmed.com).
Neurocritical care physicians and neurologists are familiar
ith the use of apneic oxygenation to prevent desaturation
hile performing brain death examinations.63-65 Apneic
xygenation has also been used to continue oxygenation during
ronchoscopies and otolaryngeal procedures.66-68
Two studies merit specific mention because they extend the
echnique to situations applicable to emergency tracheal
ntubation. In a randomized controlled trial of anesthesia
atients, Taha et al69 demonstrated no desaturation during the
ourse of 6 minutes in patients receiving 5 L/minute of oxygen
hrough a nasal catheter. Conversely, the control group
esaturated to the study cutoff of 95% in an average of 3.65
inutes. Ramachandran et al70 performed a randomized
ontrolled trial of obese patients requiring tracheal intubation
or elective surgery. The apneic oxygenation group received 5
/minute of oxygen through nasal cannulas during their apneic
eriod. The apneic oxygenation group had significant
rolongation of the time spent with a SpO2 greater than or
qual to 95% (5.29 versus 3.49 minutes), a significant increase
n patients with SpO2 greater than or equal to 95% at the 6-
inute mark (8 patients versus 1 patient), and significantly
igher minimum SpO2 (94.3% versus 87.7%).

















































Preoxygenation and Prevention of Desaturation During Emergency Airway Management Weingart & LevitanApneic oxygenation as described above will allow continued
oxygenation but will have no significant effect on carbon
dioxide levels. Although extracorporeal carbon dioxide removal,
high oscillatory flow, or acid buffers can allow apneic
ventilation, as well as oxygenation, these therapies are outside
the scope of current ED practice.
To provide apneic oxygenation during ED tracheal
intubations, the nasal cannula is the device of choice. Nasal
cannulas provide limited FiO2 to a spontaneously breathing
patient,71 but the decreased oxygen demands of the apneic state
will allow this device to fill the pharynx with a high level of
FiO2 gas.
70 By increasing the flow rate to 15 L/minute, near
100% FiO2 can be obtained. Although providing high flow
rates with a conventional, nonhumidified nasal cannula can be
uncomfortable because of its desiccating effect on the
nasopharynx, after the patient has been sedated it should cause
no deleterious effects for the short interval of airway
management. Tailor-made high-flow nasal cannulas are also
available that will humidify the oxygen, allowing flow rates up
to 40 L/minute.72
The patients’ mouths being open did not negatively affect
the FiO2 provided.
73 If any potential obstruction caused by
redundant nasal tissue is discovered, nasal trumpets will allow a
direct conduit from the nasal cannula to the oropharynx.
Although facemasks and nonrebreather masks can provide
high FiO2 levels to spontaneously breathing patients (depending
on flow rates), they provide minimal oxygen to apneic
patients,74 likely because of the 2 exhalation valves venting the
fresh gas flow. Bag-valve-mask devices provide no oxygen to
apneic patients unless manual ventilations are delivered. Even
with manual ventilations, a continuous flow of high-level FiO2
will not be available with this device.
Conventional ventilators or noninvasive ventilation machines
do not supply a continuous flow of gas when placed on
conventional or noninvasive settings. The minimal negative
inspiratory pressures generated during apneic oxygenation are
insufficient to trigger gas delivery with these machines.
Although the high-flow CPAP setups found in many ICUs can
provide both positive pressure and high FiO2 levels for apneic
oxygenation, they are not commonly available in EDs.
An additional benefit to the use of nasal cannula devices is
that they can be left on during the tracheal intubation attempts.
This has been described with an acronym, NO DESAT (nasal
oxygen during efforts securing a tube)75; it allows the continued
benefits of apneic oxygenation while tracheal intubation
techniques are performed. The nasal cannula can be placed
under a facemask (or bag-valve-mask device) during
preoxygenation, and then it remains on, administering oxygen
through the nose throughout oral tracheal intubation with
direct or video laryngoscopy.
Recommendation: Apneic oxygenation can extend the
duration of safe apnea when used after the administration of
sedatives and muscle relaxants. A nasal cannula set at 15 (
170 Annals of Emergency Medicine/minute is the most readily available and effective means of
roviding apneic oxygenation during ED tracheal intubations.
HEN AND HOW SHOULD WE PROVIDE
ANUAL VENTILATIONS DURING THE APNEIC
ERIOD?
Practitioners should not initiate laryngoscopy before full
uscle relaxation to maximize laryngeal exposure and to avoid
riggering the patient’s gag reflex and active vomiting just before
pnea. Ventilation provides 2 potential benefits during the onset
hase of muscle relaxation: ventilation and increased
xygenation through alveolar distention and reduction in
hunting.
The first benefit is minimal in most clinical scenarios. On
verage, PaCO2 increases 8 to 16 mm Hg in the first minute of
pnea and then approximately 3 mm Hg/minute
ubsequently.53 It is rare that this degree of PaCO2 increase and
H decrease will be clinically significant. An exception is a
rofound metabolic acidosis, such as severe salicylate toxicity, in
hich patients compensate for the acidosis through hyperpnea
nd tachypnea. Aggressive ventilation is needed for such patients
ecause cardiovascular collapse with cessation of self-ventilation
as been reported.76 A second exception is in situations of
ncreased intracranial pressure, in which the carbon dioxide
ncrease can lead to cerebral vasodilation.
The second benefit, increased oxygenation, is crucial;
atients starting with a pulse oximetry reading of less than or
qual to 90% will not tolerate apnea for 60 seconds. Ventilation
uring the onset phase of muscle relaxation can create alveolar
istention and lengthen the duration of safe apnea during
racheal intubation efforts, assuming it is conducted carefully.
ag-valve-mask device inspiratory pressures greater than 25 cm
2O can overwhelm the esophageal sphincter and put the
atient at risk for regurgitation and aspiration.34,35 When
roviders are inexperienced or under stress, this pressure is easily
xceeded.77 If ventilations during apnea are required, it may be
referable to use an automated device such as a handheld or
onventional ventilator with built-in inspiratory pressure limits
nd PEEP.78,79
If a bag-valve-mask device is used during the onset of
uscular relaxation, a PEEP valve will provide sustained
lveolar distention. Ventilations should be delivered slowly
during 1 to 2 seconds), involve a low volume (6 to 7 mL/kg),
nd be administered at as low a rate as tolerable for the clinical
ircumstances (6 to 8 breaths/min).80 Although not clinically
roven, there may be a benefit to head elevation in reducing the
isk of passive regurgitation in such patients, in addition to the
ignificant physiologic benefits of oxygenation in a head-
levated position.
A significant risk of positive-pressure ventilation in the
ritically ill patient involves decreased venous return and
ypotension. This is especially significant in low flow states
rom any cause (hypotension), volume depletion, acute
espiratory distress syndrome, and obstructive airway disease
with attendant risks of intrinsic PEEP). Overventilation in such











































Weingart & Levitan Preoxygenation and Prevention of Desaturation During Emergency Airway Managementpatients may precipitate hemodynamic collapse, and clinicians
must be mindful of rate, volume, and speed of ventilation in
these situations. Relative hypoventilation and resultant
permissive hypercapnia may be required to avoid hemodynamic
collapse.81
Recommendation: The risk/benefit of active ventilation
during the onset phase of muscle relaxants must be carefully
assessed in each patient. In patients at low risk for desaturation
(95% saturation), manual ventilation is not necessary. In
patients at higher risk (91% to 95% saturation), a risk-benefit
assessment should include an estimation of desaturation risk and
the presence of pulmonary pathology. In hypoxemic patients,
low-pressure, low-volume, low-rate ventilations will be required.
WHAT POSITIONING AND MANEUVERS
SHOULD THE PATIENT RECEIVE DURING THE
APNEIC PERIOD?
Apneic oxygenation requires a patent airway for oxygen to
reach the hypopharynx and be entrained into the trachea; once
the patient is sedated and paralyzed, it is imperative to keep the
posterior pharyngeal structures and tongue from occluding the
passage of gas. Head elevation, chin lift, and jaw thrust will
accomplish this in most patients; a jaw thrust alone should be
used if there is risk for cervical spine injury. In some patients, a
nasal trumpet or oral airway may also be required. Patients with
sleep apnea or obesity often need a combination of jaw
distraction, lifting of submandibular soft tissue, and nasal or
oral airways.
Positioning the patient with their external auditory meatus
on the same horizontal plane as their sternal notch maximizes
upper airway dimensions and facilitates direct laryngoscopy.82,83
Head elevation relative to the thorax also permits optimal jaw
distraction, and conversely atlanto-occipital extension pivots the
base of tongue and epiglottis against the posterior pharynx and
promotes obstruction. In all but the thinnest patients, a head-
elevated position requires lifting of the head of the bed
somewhat, plus padding under the head and upper shoulders.
The face plane of the patient should be parallel to the ceiling.
For the superobese, this positioning requires a very large ramp.
In cervical spine precautions, elevating the head relative to the
neck is not possible, but as previously noted the foot of the
stretcher should be tilted downward to improve pulmonary
function.
Cricoid pressure, considered an essential aspect of rapid
sequence tracheal intubation when it was first conceived, has
come under increasing scrutiny within anesthesia and
emergency medicine.84,85 Theoretically, the application of firm
pressure to the cricoid cartilage compresses the esophagus while
keeping the trachea patent, but in practice this is not always the
case.86 Computed tomography and magnetic resonance imaging
scanning have shown that cricoid pressure causes lateral
displacement of the esophagus in more than 90% of patients
and laryngeal/tracheal compression in 80%.87,88 Numerous
ventilation studies have found that cricoid pressure hinders bag- h
Volume , .  : March alve-mask device ventilation, increases peak inspiratory
ressure, and reduces tidal volumes.34,84,89-94 For the same
easons that the airway obstruction induced by cricoid pressure
ay preclude effective manual ventilation, it may limit the
ffectiveness of apneic oxygenation as well.
Recommendation: Patients should be positioned to
aximize upper airway patency before and during the apneic
eriod, using ear-to–sternal notch positioning. Nasal airways
ay be needed to create a patent upper airway. Once the apneic
eriod begins, the posterior pharyngeal structures should be
ept from collapsing backwards by using a jaw thrust. Cricoid
ressure may negatively affect apneic oxygenation, but studies
xamining this question in the setting of modern emergency
irway management do not exist to our knowledge.
OES THE CHOICE OF PARALYTIC AGENT
FFECT PREOXYGENATION?
The choice of paralytic agent may influence the time to
esaturation during airway management. In a study of operative
atients, the time to desaturation to 95% was 242 seconds in
atients receiving succinylcholine versus 378 seconds in a group
iven rocuronium.95 Similarly, in obese patients undergoing
urgery, the succinylcholine group desaturated to 92% in 283
econds versus 329 seconds in the rocuronium group.96 When
sed at a dose of greater than or equal to 1.2 mg/kg,
ocuronium provides intubating conditions identical to those of
uccinylcholine.97
It is hypothesized that the fasciculations induced by
uccinylcholine may cause increased oxygen use. Pretreatment
edications to prevent fasciculations minimize the difference in
esaturation times.95
Recommendation: In patients at high risk of desaturation,
ocuronium may provide a longer duration of safe apnea than
uccinylcholine.
ISK STRATIFICATION AND CONCLUSIONS
Patients requiring emergency airway management can be
isk stratified into 3 groups, according to pulse oximetry after
nitial application of high-flow oxygen. The recommended
echniques to use for patients in each group are shown in
able 2, and a logistic flow of preoxygenation steps is shown
n Figure 3.
Head-elevated positioning is simple and easy to apply in all
atients; in the patient immobilized for cervical spine injury, it
s beneficial to tilt the foot of the bed downward.
Patients at lowest risk (saturations of 96% to 100%) should
e properly positioned and receive preoxygenation; active
entilation is not needed. Passive apneic oxygenation during
racheal intubation efforts may not be necessary in these low-
isk patients, but it will extend safe apnea in the event of
epeated tracheal intubation attempts.
Patients in the 91% to 95% saturation group after receiving
igh FiO2 levels are at high risk of critical desaturation during




Preoxygenation and Prevention of Desaturation During Emergency Airway Management Weingart & Levitanemergency tracheal intubation. Positioning, preoxygenation,
and passive oxygenation should be used. For these patients,
consideration should be given to using PEEP during
preoxygenation and while awaiting muscle relaxation, but the




















CPAP or bag-valve-mask device
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*Risk categories are based on patient’s initial response to high-flow oxygen th
exhibit shunt physiology and are prone to rapid desaturation during the peri-in
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are at low risk for peri-intubation desaturation. Patients in all risk categories s
burg if there is a risk of spine injury).Figure 3. Logistic flow of preoxygenatio
172 Annals of Emergency Medicineisks and benefits of these techniques must be assessed case by
ase.
For patients initially hypoxemic with high FiO2 levels
saturation of 90% or less), aggressive efforts must be made to
set of Muscle Relaxation
(60 Seconds)





reather mask and nasal
n at 15 L/min
Nasal oxygen at 15 L/min
reather mask, CPAP, or bag-
-mask device with PEEP and
l oxygen at 15 L/min
Nasal oxygen at 15 L/min
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Weingart & Levitan Preoxygenation and Prevention of Desaturation During Emergency Airway Managementmaximize saturation before tracheal intubation. These patients
will require PEEP during preoxygenation, ventilation during the
onset of phase of muscle relaxants, and passive oxygenation
during tracheal intubation.
Videos of the techniques described in this article can be
found at http://emcrit.org/preoxygenation.
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